- Conditions
- Glabellar Lines
- Interventions
- AGN-151586, BOTOX
- Drug
- Lead sponsor
- AbbVie
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 120 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2026 – 2027
- U.S. locations
- 8
- States / cities
- Glendale, Arizona • Newport Beach, California • Vista, California + 5 more
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results come from ClinicalTrials.gov. When the live registry is unavailable, a clearly labeled stored copy may be shown.
These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 25–48
of 286
matching trials from the live ClinicalTrials.gov search.
- Conditions
- Stroke
- Interventions
- Botox®, saline solution
- Other
- Lead sponsor
- New York Presbyterian Hospital
- Other
- Eligibility
- 18 Years to 85 Years
- Enrollment
- 12 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2009 – 2010
- U.S. locations
- 1
- States / cities
- New York, New York
- Conditions
- Overactive Bladder
- Interventions
- onabotulinumtoxinA, Normal saline
- Biological · Drug
- Lead sponsor
- Allergan
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 254 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2013 – 2017
- U.S. locations
- 40
- States / cities
- Huntsville, Alabama • Anchorage, Alaska • Laguna Hills, California + 35 more
- Conditions
- Overactive Bladder, Bladder Pain Syndrome, Migraine Disorders, Overactive Bladder Syndrome, Overactive Detrusor, Migraine, Interstitial Cystitis
- Interventions
- Ubrogepant, Rimegepant, Atogepant, Eptinezumab, Fremanezumab, Galcanezumab, Erenumab, Botulinum toxin A
- Drug
- Lead sponsor
- The Cleveland Clinic
- Other
- Eligibility
- 18 Years and older · Female only
- Enrollment
- 200 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2024 – 2026
- U.S. locations
- 1
- States / cities
- Cleveland, Ohio
- Conditions
- Urinary Incontinence, Stress, Urinary Incontinence, Urge
- Interventions
- Botox® injection, Mid-urethral sling
- Drug · Device
- Lead sponsor
- NICHD Pelvic Floor Disorders Network
- Network
- Eligibility
- 21 Years and older · Female only
- Enrollment
- 150 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2020 – 2024
- U.S. locations
- 8
- States / cities
- Birmingham, Alabama • La Jolla, California • San Diego, California + 5 more
- Conditions
- Lower Urinary Tract Discomfort, Stent Pain
- Interventions
- Botox
- Drug
- Lead sponsor
- University of California, Irvine
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 15 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2014 – 2017
- U.S. locations
- 1
- States / cities
- Orange, California
- Conditions
- Temporomandibular Joint Disorders, Bruxism, Temporomandibular Joint Dysfunction Syndrome, Myofascial Pain Dysfunction Syndrome, Temporomandibular Joint
- Interventions
- onabotulinumtoxinA
- Drug
- Lead sponsor
- Washington University School of Medicine
- Other
- Eligibility
- 18 Years to 65 Years
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2015
- U.S. locations
- 1
- States / cities
- St Louis, Missouri
- Conditions
- Platysma Prominence
- Interventions
- NT 201, NT 201 Placebo
- Drug
- Lead sponsor
- Merz Aesthetics GmbH
- Industry
- Eligibility
- 18 Years to 65 Years
- Enrollment
- 73 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2023 – 2024
- U.S. locations
- 7
- States / cities
- Washington D.C., District of Columbia • Aventura, Florida • Coral Gables, Florida + 3 more
- Conditions
- Sialorrhea
- Interventions
- MYOBLOC
- Drug
- Lead sponsor
- Solstice Neurosciences, LLC, a subsidiary of US WorldMeds, LLC
- Industry
- Eligibility
- 18 Years to 85 Years
- Enrollment
- 187 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2015 – 2017
- U.S. locations
- 26
- States / cities
- Phoenix, Arizona • Scottsdale, Arizona • Loma Linda, California + 22 more
- Conditions
- Chronic Migraine
- Interventions
- onabotulinumtoxinA
- Drug
- Lead sponsor
- Cady, Roger, M.D.
- Individual
- Eligibility
- 18 Years and older
- Enrollment
- 44 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2014 – 2015
- U.S. locations
- 1
- States / cities
- Springfield, Missouri
- Conditions
- Frown Lines
- Interventions
- DaxibotulinumtoxinA for injection
- Biological
- Lead sponsor
- Revance Therapeutics, Inc.
- Industry
- Eligibility
- 18 Years to 65 Years
- Enrollment
- 61 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2019 – 2020
- U.S. locations
- 2
- States / cities
- Boca Raton, Florida • Coral Gables, Florida
- Conditions
- Cervical Dystonia
- Interventions
- Botulinum toxin A
- Drug
- Lead sponsor
- University of California, San Francisco
- Other
- Eligibility
- 18 Years to 75 Years
- Enrollment
- 10 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2008 – 2011
- U.S. locations
- 1
- States / cities
- San Francisco, California
- Conditions
- Episodic Migraine
- Interventions
- BOTOX, Placebo
- Drug
- Lead sponsor
- AbbVie
- Industry
- Eligibility
- 18 Years to 65 Years
- Enrollment
- 775 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2021 – 2024
- U.S. locations
- 82
- States / cities
- Hoover, Alabama • Huntsville, Alabama • Phoenix, Arizona + 69 more
- Conditions
- Wrinkles
- Interventions
- Onabotulinum Toxin A, Incobotulinum Toxin A
- Drug
- Lead sponsor
- Northwestern University
- Other
- Eligibility
- 20 Years to 65 Years
- Enrollment
- 20 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2013 – 2027
- U.S. locations
- 1
- States / cities
- Chicago, Illinois
- Conditions
- Cervical Dystonia
- Interventions
- Botox injection, Physical Therapy, Transcranial magnetic stimulation (TMS)
- Drug · Behavioral · Procedure
- Lead sponsor
- University of Florida
- Other
- Eligibility
- 18 Years to 80 Years
- Enrollment
- 16 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2014 – 2017
- U.S. locations
- 1
- States / cities
- Gainesville, Florida
- Conditions
- Wrinkle
- Interventions
- Botulinum toxin type A
- Drug
- Lead sponsor
- Global Aesthetics LLC
- Other
- Eligibility
- 20 Years to 65 Years
- Timeline
- 2024 – 2027
- U.S. locations
- 2
- States / cities
- Cisco, Texas • Lubbock, Texas
- Conditions
- Benign Prostatic Hyperplasia, Overactive Bladder
- Interventions
- Intravesical Botox injection
- Drug
- Lead sponsor
- University Hospitals Cleveland Medical Center
- Other
- Eligibility
- 40 Years and older · Male only
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2026 – 2027
- U.S. locations
- 3
- States / cities
- Cleveland, Ohio • Lyndhurst, Ohio • Richmond Heights, Ohio
- Conditions
- Urinary Incontinence, Overactive Bladder
- Interventions
- Botulinum toxin type A, Placebo
- Biological · Drug
- Lead sponsor
- Ipsen
- Industry
- Eligibility
- 18 Years to 80 Years
- Enrollment
- 227 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2016 – 2019
- U.S. locations
- 32
- States / cities
- Birmingham, Alabama • Tucson, Arizona • Long Beach, California + 27 more
- Conditions
- Lower Limb or Combined Lower Limb and Upper Limb Spasticity Due to Stroke or Traumatic Brain Injury
- Interventions
- NT 201, Placebo
- Drug
- Lead sponsor
- Merz Pharmaceuticals GmbH
- Industry
- Eligibility
- 18 Years to 85 Years
- Enrollment
- 603 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2019 – 2027
- U.S. locations
- 15
- States / cities
- Birmingham, Alabama • Little Rock, Arkansas • Downey, California + 11 more
- Conditions
- Upper Limb Spasticity
- Interventions
- ABBV-950, BOTOX, Placebo for ABBV-950
- Biological · Drug
- Lead sponsor
- AbbVie
- Industry
- Eligibility
- 18 Years to 80 Years
- Enrollment
- 1 participant
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2024
- U.S. locations
- 9
- States / cities
- Carlsbad, California • Downey, California • Fresno, California + 6 more
- Conditions
- Moderate to Severe Glabellar Frown Lines
- Interventions
- NT 201
- Drug
- Lead sponsor
- Merz Aesthetics GmbH
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 241 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2019 – 2020
- U.S. locations
- 5
- States / cities
- Encino, California • Newport Beach, California • San Diego, California + 2 more
- Conditions
- Glabellar Frown Lines
- Interventions
- botulinum toxin, Placebo
- Biological
- Lead sponsor
- Galderma R&D
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 300 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2020 – 2021
- U.S. locations
- 13
- States / cities
- Manhattan Beach, California • Vista, California • New Orleans, Louisiana + 8 more
- Conditions
- Overactive Bladder
- Interventions
- onabotulinumtoxinA, normal saline
- Biological · Drug
- Lead sponsor
- Allergan
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 557 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2009 – 2011
- U.S. locations
- 1
- States / cities
- Newport Beach, California
- Conditions
- Axillary Hyperhidrosis
- Interventions
- Botulinum Toxin Type A, Suction-Curettage
- Drug · Device
- Lead sponsor
- Northwestern University
- Other
- Eligibility
- 18 Years to 65 Years
- Enrollment
- 20 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2010 – 2011
- U.S. locations
- 1
- States / cities
- Chicago, Illinois